CO4480024A1 - Nuevos benzopiranos y otros antagonistas de b4(ltb4) leuco- triena fusionada con benzo - Google Patents

Nuevos benzopiranos y otros antagonistas de b4(ltb4) leuco- triena fusionada con benzo

Info

Publication number
CO4480024A1
CO4480024A1 CO95046243A CO95046243A CO4480024A1 CO 4480024 A1 CO4480024 A1 CO 4480024A1 CO 95046243 A CO95046243 A CO 95046243A CO 95046243 A CO95046243 A CO 95046243A CO 4480024 A1 CO4480024 A1 CO 4480024A1
Authority
CO
Colombia
Prior art keywords
ltb4
antagonists
benzopyrans
benzo
new
Prior art date
Application number
CO95046243A
Other languages
English (en)
Inventor
Mark Anthony Dombroski
Kevin Koch
Anthony Daniel Piscopio
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO4480024A1 publication Critical patent/CO4480024A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS BENZOPIRANOS Y A OTROS ANTAGONISTAS DE B4(LTB4) LEUCOTRIENA FU- SIONADOS CON BENZO, A LAS SALES FARMACEUTICAMENTE ACEPTABLES DE TALES COMPUESTOS, A LAS COMPOSICIO- NES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS, Y AL PROCEDIMIENTO PARA USAR TALES COMPUESTOS COMO ANTAGONISTAS DE LTB4. LOS COMPUESTOS Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE ESTA INVENCION INHIBEN LA ACCION DEL LTB4 Y POR LO TANTO SON UTI- LES EN EL TRATAMIENTO DE ENFERMEDADES INDUCIDAS POR LTB4 TALES COMO TRASTORNOS INFLAMATORIOS IN- CLUIDA ARTRITIS REUMATOIDE, OSTEOARTRITIS, ENFER- MEDAD INFLAMATORIA DE LOS INTESTINOS, PSORIASIS, Y OTROS TRASTORNOS DE LA PIEL TALES COMO ECZEMA, ERITEMA, PRURITO, Y ACNE, GOLPE Y OTRAS FORMAS DE DANO DE PERFUSION, RECHAZO DE INJERTO, ENFERMEDA- DES AUTOINMUNES, ASMA, Y OTROS ESTADOS DONDE OCU- RRE LA INFILTRACION, NEUTROFILICA ACENTUADA. FIGURA 1
CO95046243A 1994-10-13 1995-10-04 Nuevos benzopiranos y otros antagonistas de b4(ltb4) leuco- triena fusionada con benzo CO4480024A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32287694A 1994-10-13 1994-10-13

Publications (1)

Publication Number Publication Date
CO4480024A1 true CO4480024A1 (es) 1997-07-09

Family

ID=23256829

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95046243A CO4480024A1 (es) 1994-10-13 1995-10-04 Nuevos benzopiranos y otros antagonistas de b4(ltb4) leuco- triena fusionada con benzo

Country Status (23)

Country Link
US (2) US6051601A (es)
EP (1) EP0785930A1 (es)
JP (1) JP2983295B2 (es)
KR (1) KR100232341B1 (es)
CN (1) CN1160399A (es)
AU (1) AU696890B2 (es)
BR (1) BR9504385A (es)
CA (1) CA2201742A1 (es)
CO (1) CO4480024A1 (es)
CZ (1) CZ111797A3 (es)
FI (1) FI971524A (es)
HU (1) HUT77515A (es)
IL (1) IL115529A0 (es)
MX (1) MX9702731A (es)
NO (1) NO971672L (es)
NZ (1) NZ285156A (es)
PE (1) PE10897A1 (es)
PL (1) PL319688A1 (es)
RU (1) RU2128655C1 (es)
TR (1) TR199501270A2 (es)
TW (1) TW304941B (es)
WO (1) WO1996011920A1 (es)
ZA (1) ZA958597B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU713701B2 (en) * 1996-09-16 1999-12-09 Pfizer Inc. Processes and intermediates for preparing substituted chromanol derivatives
EP0961617A4 (en) * 1996-12-13 2002-08-07 Lilly Co Eli LEUKOTRINE ANTAGONISTS FOR TREATING FOCAL BRAIN CHEMISTRY
IL128731A0 (en) * 1998-03-12 2000-01-31 Pfizer Prod Inc Method of preventing allograft rejection
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
BR0206771A (pt) * 2001-01-30 2004-02-25 Pfizer Prod Inc Processos para a preparação de cidos cromanilbenzóicos
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
AU2003243089B2 (en) 2002-06-19 2010-01-07 Biovitrum Ab (Publ) Novel compounds, their use and preparation
RU2007101510A (ru) * 2004-07-22 2008-08-27 Фармаци Корпорейшн (US) Композиции для лечения воспаления и боли с использованием комбинации селективного ингибитора сох-2 и антагониста рецептора ltb4
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
MX2007007103A (es) 2004-12-13 2008-03-10 Lilly Co Eli Derivados espiro como inhibidores de lipoxigenasa.
WO2006093548A1 (en) 2005-02-25 2006-09-08 Galileo Pharmaceuticals, Inc. Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
CA2651817A1 (en) 2006-05-11 2007-11-22 Janssen Pharmaceutica N.V. 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
JP2009536953A (ja) 2006-05-11 2009-10-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃｅｔｐ阻害剤としての１，２，３，４−テトラヒドロ−キノリン誘導体
AP2011005613A0 (en) 2008-09-11 2011-04-30 Pfizer Heteroaryls amide derivatives and their use as glucokinase activators.
AU2010222589B2 (en) 2009-03-11 2012-08-16 Pfizer Inc. Benzofuranyl derivatives used as glucokinase inhibitors
WO2013123081A2 (en) * 2012-02-14 2013-08-22 Children's Hospital Medical Center Use of small molecule inhibitors targeting the interaction between rac gtpase and p67 (phox)
CN102920692A (zh) * 2012-10-25 2013-02-13 中国人民解放军第二军医大学 (e)-2-(1-羟基-4-环己酮)乙基咖啡酸酯在制备防治类风湿关节炎的药物中的应用
US9745253B2 (en) 2015-03-13 2017-08-29 Forma Therapeutics, Inc. Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
WO2017040963A1 (en) 2015-09-03 2017-03-09 Forma Therapeutics, Inc. [6,6] fused bicyclic hdac8 inhibitors
EP3383389B1 (en) 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
EP3383868B1 (en) 2015-11-30 2022-10-05 Merck Sharp & Dohme LLC Aryl sulfonamides as blt1 antagonists
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists
WO2018071687A1 (en) * 2016-10-13 2018-04-19 The Regents Of The University Of California Methods of treating pruritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
CA2019335C (en) * 1989-06-27 2000-08-01 Mitoshi Konno Phenylalkan (en)oic acids
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5051438A (en) * 1990-05-16 1991-09-24 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists
US5550152A (en) * 1992-01-23 1996-08-27 Pfizer Inc. Benzopyran and related LTB4 antagonists
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.

Also Published As

Publication number Publication date
JP2983295B2 (ja) 1999-11-29
US6133286A (en) 2000-10-17
ZA958597B (en) 1997-04-14
KR970706270A (ko) 1997-11-03
KR100232341B1 (ko) 2000-07-01
FI971524A0 (fi) 1997-04-11
NO971672L (no) 1997-06-11
EP0785930A1 (en) 1997-07-30
NO971672D0 (no) 1997-04-11
CZ111797A3 (cs) 1998-07-15
FI971524A (fi) 1997-04-11
PL319688A1 (en) 1997-08-18
US6051601A (en) 2000-04-18
NZ285156A (en) 1999-01-28
CN1160399A (zh) 1997-09-24
TW304941B (es) 1997-05-11
HUT77515A (hu) 1998-05-28
RU2128655C1 (ru) 1999-04-10
BR9504385A (pt) 1997-05-27
PE10897A1 (es) 1997-04-21
AU696890B2 (en) 1998-09-24
JPH09512035A (ja) 1997-12-02
MX9702731A (es) 1997-06-28
TR199501270A2 (tr) 1996-06-21
IL115529A0 (en) 1996-01-19
CA2201742A1 (en) 1996-04-25
AU2416795A (en) 1996-05-06
WO1996011920A1 (en) 1996-04-25

Similar Documents

Publication Publication Date Title
CO4480024A1 (es) Nuevos benzopiranos y otros antagonistas de b4(ltb4) leuco- triena fusionada con benzo
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
SV2002000289A (es) Antagonistas del factor liberador de la corticotropina ref. pc10759/20117/bb
DE3851152T2 (de) Cyclosporin-augenmittel.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
AR002289A1 (es) Derivados de acetamida, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y las aplicaciones de dichos compuestos comoansioliticos y en el tratamiento de enfermedades inmuno-inflamatorias.
DE69325374D1 (de) Dehnbare absorbierende struktur
ES2038608T3 (es) Un compuesto de dibenz(b,e)oxepina.
PA8508201A1 (es) Derivados de heterociclo-alquilsulfonil pirazolo como agentes anti-inflamatorios/analgesicos
ES2172695T3 (es) Carboxamidas y sulfonamidas de benzofurano.
Gunderson Pharmacotherapy for patients with borderline personality disorder
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
AR012193A1 (es) Nuevas combinaciones terapeuticas
AR002704A1 (es) 2-(2-n-alcoxifenil)-purin-6-onas 9-sustituidas, procedimiento para su preparacion, composiciones farmaceuticas que las contienen y su uso parapreparar composiciones farmaceuticas.
ES2131513T3 (es) Utilizacion de interferon-beta 2a humano para la preparacion de medicamentos.
ES2111175T3 (es) Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias.
MX9203409A (es) Proteinas bcrfi como inhibidores de la gama interferona.
BR9810396A (pt) Processos para usar composições contendo imidazoldioxolano de diclorofenila para tratar dermatite seborréica, caspa, psorìase e acne, e composições dos mesmos
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
IT9067661A0 (it) Cuscinetto volvente con almeno un anello del cuscinetto diviso trasversalmente alla direzione dell'asse.
ES2112832T3 (es) Derivados carbamoilicos.
ES2138366T3 (es) Indol carbamatos como antagonistas de leucotrienos.
MX9405380A (es) Benzotiofenos y benzofuranos como agentes de uso terapeutico en eltratamiento de enfermedades inflamatorias del intestino y metodos contrala inflamacion.
STEINER PAPERS IN EARLY AMERICAN PRIZE CASES